Metabolised by CYP3A4. Inducer of CYP3A4. Two references consider it safe.
Chemical description
Antihistamine without sedative effect used (10 mg/d p.o.) in allergic rhinitis/conjunctivitis and in histamine mediated pruritus and urticaria. The same general structure as cyproheptadine (PSP). Metabolized by CYP3A4. Main metabolite is decarboxyethoxyloratidine with an elimination half time of 19 hours.
Personal communication
Clinical experience (Swedish) seems to point to non-porphyrinogenicity.
Thunell: occasionally observed to be tolerated.
Andersson, patient reports: tolerated (n=13).
Andersson C, patient reports: tolerated (n=4).
IPNet drug reports
Uneventful use reported in 28 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes
R06A /
R06AX or
go back.